Israel Englander Ptc Therapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 317,579 shares of PTCT stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

317,579

Previous 142,290 123.19%

Holding current value

$13.7 Million

Previous $4.14 Million 134.62%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $4.33 Million - $7.03 Million	175,289 Added 123.19%	317,579 $9.71 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $8.89 Million - $11.8 Million	-368,286 Reduced 72.13%	142,290 $4.14 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $9.1 Million - $14.8 Million	503,715 Added 7341.71%	510,576 $14.1 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $277,184 - $405,485	6,861 New	6,861 $279,000
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $4.77 Million - $7.79 Million	-142,220 Reduced 32.22%	299,133 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $18.5 Million - $23.8 Million	441,353 New	441,353 $22.2 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $861,713 - $1.15 Million	-25,854 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $474,460 - $561,677	13,418 Added 107.9%	25,854 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $249,262 - $301,323	6,735 Added 118.14%	12,436 $463,000
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $5.51 Million - $7.16 Million	-145,077 Reduced 96.22%	5,701 $241,000
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $6.33 Million - $9.33 Million	135,331 Added 876.1%	150,778 $7.14 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $740,838 - $1.04 Million	15,447 New	15,447 $943,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $1.69 Million - $2.18 Million	-39,682 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$32.37 - $59.36 $1.3 Million - $2.38 Million	-40,159 Reduced 50.3%	39,682 $1.77 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $3.84 Million - $5.96 Million	-119,038 Reduced 59.85%	79,841 $3.84 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $35 Million - $49.8 Million	-1,034,449 Reduced 83.87%	198,879 $6.73 Million
Q2 2019 Aug 15, 2019	BUY	$35.42 - $45.0 $41.5 Million - $52.8 Million	1,172,800 Added 1937.62%	1,233,328 $55.5 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $16.9 Million - $21.5 Million	-477,473 Reduced 88.75%	60,528 $10.4 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $10.5 Million - $14.8 Million	374,690 Added 229.43%	538,001 $20.3 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $5.5 Million - $8.58 Million	-184,434 Reduced 53.04%	163,311 $5.61 Million
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $2.58 Million - $3.64 Million	-76,161 Reduced 17.97%	347,745 $16.3 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $6.52 Million - $12.1 Million	-253,595 Reduced 37.43%	423,906 $14.3 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $2.14 Million - $3.99 Million	122,296 Added 22.03%	677,501 $18.3 Million
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $4.46 Million - $6.15 Million	294,572 Added 113.02%	555,205 $9.26 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $4.38 Million - $5.63 Million	260,633	260,633 $5.22 Million

Others Institutions Holding PTCT

# of Institutions

220

Shares Held

79.3M

Call Options Held

122K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.09B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account